For the first time, a new gene editing technology called base editing was used to modify immune cells and successfully treat a teen with treatment-resistant leukemia. A month afterward, 13-year ...

ABOUT THIS EVENT Kelly ETFs (Nasdaq: XDNA), celebrating 10 years of CRISPR, with the launch of the CRISPR & Gene Editing Technology ETF, rings the Nasdaq Closing Bell remotely from across the country.

Researchers at the National University of Singapore (NUS) have developed a scalable, non-viral technology that efficiently delivers genetic material into human immune cells.

By Nadia Kounang, CNN For the first time, a new gene editing technology called base editing was used to modify immune cells and successfully treat a teen with treatment-resistant leukemia. A month ...